Literature DB >> 2732686

The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein.

M J Endres1, D R Jacoby, R S Janssen, F Gonzalez-Scarano, N Nathanson.   

Abstract

Reassortant bunyaviruses derived from two members of the California serogroup (La Crosse/original and Tahyna/181-57) viruses were used to demonstrate that the large Mr viral protein (L) is encoded by the L RNA segment. Radiolabelled viral proteins were analysed by discontinuous SDS-PAGE. The L protein of La Crosse virus was observed to migrate ahead of its Tahyna virus counterpart when electrophoresed through a 5% acrylamide resolving gel. Among the reassortant viruses, the L protein phenotype segregated with the viral L RNA segment. After confirming the genotype of the viruses used in this study, it was concluded that the L RNA species of California serogroup viruses codes for the L protein, the presumed viral polymerase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732686     DOI: 10.1099/0022-1317-70-1-223

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs.

Authors:  P Vialat; M Bouloy
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

2.  Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment.

Authors:  M J Endres; C Griot; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA.

Authors:  Samantha S Soldan; Matthew L Plassmeyer; Meghan K Matukonis; Francisco González-Scarano
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment.

Authors:  J A Suzich; L T Kakach; M S Collett
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Genomic stability of La Crosse virus during vertical and horizontal transmission.

Authors:  G D Baldridge; B J Beaty; M J Hewlett
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.

Authors:  A Pekosz; C Griot; K Stillmock; N Nathanson; F Gonzalez-Scarano
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

7.  Polygenic control of neuroinvasiveness in California serogroup bunyaviruses.

Authors:  C Griot; A Pekosz; D Lukac; S S Scherer; K Stillmock; D Schmeidler; M J Endres; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Analysis of LaCrosse virus S mRNA 5' termini in infected mosquito cells and Aedes triseriatus mosquitoes.

Authors:  D K Dobie; C D Blair; L J Chandler; A Rayms-Keller; M M McGaw; L P Wasieloski; B J Beaty
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

9.  La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic.

Authors:  Samantha S Soldan; Bradley S Hollidge; Valentina Wagner; Friedemann Weber; Francisco González-Scarano
Journal:  Virology       Date:  2010-05-31       Impact factor: 3.616

10.  Potential for La Crosse virus segment reassortment in nature.

Authors:  Sara M Reese; Bradley J Blitvich; Carol D Blair; Dave Geske; Barry J Beaty; William C Black
Journal:  Virol J       Date:  2008-12-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.